NIH delivering new COVID-19 testing technologies to meet U.S. demand | National Institutes of Health (NIH)
BARDA on Twitter: "#MakingCountermeasures Day 9: @mesabiotech's Accula™ #SARSCoV2 Tests provides results in just 30 mins! The system provides a decentralized testing solution at point of care to expand #COVID testing options.
Articles with Mesa Biotech, Inc
SARS-CoV-2 Test
Patient FS
Thermo Fisher Scientific to acquire point-of-care molecular
Mesa Biotech wins NIH contract to accelerate Covid-19 test production
QIAGEN - Diagnostic companies are stepping up together to address the need for #COVID19testing. This graphic shows available COVID-19 tests supported by BARDA, from QIAGEN, Mesa Biotech, Inc., Cepheid, GenMark Diagnostics, Inc .,
Analizador de proteínas automático - PA120 - Genrui Biotech Inc. - por nefelometría / de laboratorio / de mesa
Hong Cai - Independent Consultant - Self-employed | LinkedIn